13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-14

Quality of life in patients with atrial fibrillation

Berndt Lüderitz, Susanne Herwig, Werner Jung.
Department of Medicine and Cardiology, University of Bonn, Bonn, Germany

Introduction

The efficacy of a therapy has been primarily based on objective criteria such as mortality and morbidity. In addition to these objective criteria, interest has increased in recent years in the measurement of quality of life in relation to health care. Quality of life is now the new "catch phrase" in medicine. Like happiness, it is one of those terms that we all understand but for which adequate definitions do not exist. It is generally agreed that quality of life should be measured as an integral component of most trials, particularly where treatments are given with an intention to palliate or reduce symptoms1. The term quality of life suggests an abstract and philosophical approach, but in reality most approaches used in medical contexts do not attempt to include more general notions such as life satisfaction or standard of living, and rather tend to concentrate on aspects of personal experience that might be related to health and health care2. The incorporation of quality of life measurements in clinical studies is fortunately receiving a higher priority and often provides information that would be unobtainable by other means. It is important to distinguish the different applications of quality of life measure because instruments that have proven useful when applied in one context may be less appropriate elsewhere. A good research tool may be impractical for clinical uses. Generally, more attention has been given to the use of quality of life instruments in clinical trials than to an examination of their value in routine clinical care, medical audit, or resource allocation1-4.

 

backward

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.